Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714440 · ClinicalTrials.gov registry record
Genomics of Kidney Transplantation
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,552
- Enrollment target
NCT01714440: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT01714440 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,552 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01714440 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,552 participants
- Enrollment target
Study Summary
The major aim of this research study is to investigate the relationship between genetic variation in DNA (inherited code material in the cells of the body) and factors affecting transplant outcomes, like the drugs people receive or the way their immune systems work, for example. To do this, investigators will collect blood samples from participants. Genetic material will be separated from each blood sample and analyzed, looking for genetic variation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,552 participants |
| Start Date | 2012-08 |
| Est. Completion | 2017-01 |
What the finished NCT01714440 record still lists
NCT01714440 is an observational study that tracks outcomes without assigning an intervention. Its 1,552 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01714440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01714440 about?
NCT01714440 is a clinical study titled "Genomics of Kidney Transplantation". The major aim of this research study is to investigate the relationship between genetic variation in DNA (inherited code material in the cells of the body) and factors affecting transplant outcomes, like the drugs people receive or the way their immune systems work, for example. To do this, investig...
What is the current status of trial NCT01714440?
This trial is currently completed. The enrollment target is 1,552 participants. The study started on 2012-08. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT01714440?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia